INNT
TOTAL INVALIDATION PROCESSED BY THE IB
03/03/2024
Back to search
Official data from USPTO
NANOXRAY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NANOXRAY
ST13
US500000079107537Class
5, 10, 42, 44
Filing
79107537
Registration
4248033
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
03/03/2024
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
11/09/2011
Registration date
11/27/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/09/2023
Last transaction
06/09/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Paris, FR
Examiner
MURRAY, TY
Law office
M40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Nanobiotix
Nanobiotix
Representatives
James R Menker Holley & Menker, PA
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Preparations for medical use particularly for the diagnosis and treatment of tumors; preparations for medical use particularly for the diagnosis and treatment of tumors using radiation treatment; radioactive substances for medical use for the diagnosis and treatment of tumors using radiation treatment; radiological contrast substances for medical use; chemical reagents for medical use; bacteriological preparations for medical use; enzymes for medical use; enzyme preparations for medical use; diagnostic preparations for medical use; antibiotics; antiseptics; health care preparations for treating cancer; biological preparations for medical use for the treatment of cancer; chemical preparations for medical or pharmaceutical use particularly for use in treating cancer; drugs for medical use for use in the treatment of cancer; medicines for human purposes for use in the treatment of cancer; restorative medicine for use in the treatment of oncological diseases; chemical-pharmaceutical preparations for use in treating oncological disease and disorders; pharmaceutical preparations for use in treating oncological disease and disorders
Class 10
Apparatus for use in medical analysismedical X-ray apparatusdiagnostic apparatus for medical usemedical X-ray apparatus; radiology screens for medical use; X-ray photographs for medical purposes; medical X-ray apparatus and installationsmounts for the production of X-raysfor medical use; X-ray protection devices for medical useradiology screens; special furniture for medical usetherapeutic mattressesbedsseats and cushions
Class 42
Scientific and technological servicesresearch and design services in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications for use in nanomedicine which is nanotechnology applied to medicine; scientific and technological evaluationsestimates and investigations provided by engineersresearchers in the field of nanomedicine; technical project studiestechnical research in the field of nanomedicine; industrial analysis and research services in the field of nanomedicine; chemistry serviceschemistry consultation; expert appraisals in the field of engineeringconsultation in the field of engineering; technical research in the field of nanomedicine
Class 44
Health services particularly in the field of nanomedicineuse of nanomedicine in disease management programs; medical services particularly in the field of nanomedicineuse of nanomedicine in disease management programs
Publications
History of USPTO decisions and trademark events.
42 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/09/2024
INPC
INVALIDATION PROCESSED
02/09/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
02/09/2024
C71T
CANCELLED SECTION 71
06/09/2023
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/27/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/26/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/17/2019
71AG
REGISTERED-SEC.71 ACCEPTED
07/17/2019
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
07/04/2019
PR71
POST REGISTRATION ACTION MAILED - SEC.71
01/17/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/17/2019
ES71
TEAS SECTION 71 RECEIVED
11/27/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/25/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/06/2013
FIMP
FINAL DISPOSITION PROCESSED
03/06/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/27/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
11/27/2012
GPNX
NOTIFICATION PROCESSED BY IB
10/16/2012
PUBO
PUBLISHED FOR OPPOSITION
09/11/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/22/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/22/2012
NPUB
NOTICE OF PUBLICATION
08/22/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/09/2012
ALIE
ASSIGNED TO LIE
08/09/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/27/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/26/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/26/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/26/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/26/2012
RFNT
REFUSAL PROCESSED BY IB
03/27/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/05/2012
RFRR
REFUSAL PROCESSED BY MPU
03/05/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/02/2012
CNRT
NON-FINAL ACTION WRITTEN
03/01/2012
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
03/01/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/01/2012
CNRT
NON-FINAL ACTION WRITTEN
02/29/2012
DOCK
ASSIGNED TO EXAMINER
02/27/2012
MAFR
APPLICATION FILING RECEIPT MAILED
01/17/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/13/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/12/2012
Continuous trademark protection
Get notified about every new filing that threatens NANOXRAY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.